Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting vaccines to dendritic cells.

Camilla Foged1, Anne Sundblad, Lars Hovgaard

  • 1Department of Pharmaceutics, The Royal Danish School of Pharmacy, Copenhagen. cfo@dfh.dk

Pharmaceutical Research
|April 6, 2002
PubMed
Summary

Dendritic cells (DC) are key antigen-presenting cells (APC) crucial for initiating immune responses. Targeting vaccines to DCs can enhance vaccine potency and safety for improved immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy.

Scientific reports·2026
Same author

Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472].

Acta pharmaceutica Sinica. B·2025
Same author

Combination of Molecular Dynamics Simulations and Machine Learning Reveals Structural Characteristics of Stereochemistry-Specific Interdigitation of Synthetic Monomycoloyl Glycerol Analogs.

Journal of chemical information and modeling·2025
Same author

[Tularaemia is often underdiagnosed].

Ugeskrift for laeger·2025
Same author

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25.

Nature nanotechnology·2025

Area of Science:

  • Immunology
  • Vaccinology
  • Cell Biology

Background:

  • Dendritic cells (DCs) are potent antigen-presenting cells (APCs) superior to B-cells and macrophages in initiating primary immune responses.
  • DCs are strategically located at pathogen entry sites, optimizing antigen capture and immune stimulation.
  • Current vaccination strategies aim to mimic pathogen invasiveness to engage the immune system.

Purpose of the Study:

  • To review DC physiology and its role in immune responses.
  • To explore novel vaccination strategies targeting DCs.
  • To highlight the need for DC-targeted vaccine delivery systems.

Main Methods:

  • Literature review of DC physiology.
  • Analysis of current vaccination strategies targeting DCs.
  • Discussion of multifunctional vaccine drug delivery systems (DDS).

Main Results:

  • DCs possess a unique capacity for antigen uptake and MHC-restricted immune stimulation.
  • Targeting vaccines to DCs is a promising approach to enhance immunogenicity and safety.
  • Development of DC-specific DDS with adjuvant properties is crucial for optimal immune responses.

Conclusions:

  • DCs are central to initiating primary immune responses, making them ideal targets for vaccination.
  • Directing vaccines to DCs can significantly improve vaccine efficacy and safety profiles.
  • Further research into DC-targeting DDS is essential for advancing modern vaccinology.

Related Experiment Videos